Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.105 AUD | +5.24% | +11.62% | +256.45% |
02/07 | Mesoblast to File Biological License Application with US FDA for Cellular Therapy | MT |
01/07 | Mesoblast to File Biologics License Application for Ryoncil | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+256.45% | 81Cr | |
+16.73% | 4.44TCr | |
+41.98% | 4TCr | |
-10.96% | 3.77TCr | |
+29.70% | 3.15TCr | |
-9.23% | 2.73TCr | |
+12.40% | 2.63TCr | |
+42.40% | 1.38TCr | |
+29.97% | 1.25TCr | |
-7.85% | 1.13TCr |
- Stock Market
- Equities
- MSB Stock
- News Mesoblast Limited
- Mesoblast : Maxim Downgrades Mesoblast to Hold From Buy